» Articles » PMID: 38339362

Social and Biological Determinants in Lung Cancer Disparity

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Feb 10
PMID 38339362
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer remains a leading cause of death in the United States and globally, despite progress in treatment and screening efforts. While mortality rates have decreased in recent years, long-term survival of patients with lung cancer continues to be a challenge. Notably, African American (AA) men experience significant disparities in lung cancer compared to European Americans (EA) in terms of incidence, treatment, and survival. Previous studies have explored factors such as smoking patterns and complex social determinants, including socioeconomic status, personal beliefs, and systemic racism, indicating their role in these disparities. In addition to social factors, emerging evidence points to variations in tumor biology, immunity, and comorbid conditions contributing to racial disparities in this disease. This review emphasizes differences in smoking patterns, screening, and early detection and the intricate interplay of social, biological, and environmental conditions that make African Americans more susceptible to developing lung cancer and experiencing poorer outcomes.

Citing Articles

Translating premalignant biology to accelerate non-small-cell lung cancer interception.

Mazzilli S, Rahal Z, Rouhani M, Janes S, Kadara H, Dubinett S Nat Rev Cancer. 2025; .

PMID: 39994467 DOI: 10.1038/s41568-025-00791-1.


Trend Analysis of Lung Cancer Incidence and Mortality in Xiamen (2011-2020).

Cong J, Chi J, Zeng J, Lin Y Risk Manag Healthc Policy. 2024; 17:2375-2384.

PMID: 39381616 PMC: 11460350. DOI: 10.2147/RMHP.S477529.


Identifying priority populations for lung cancer screening intervention using neighborhood-level factors and cancer registry data.

Tipre M, Picone C, Demanelis K, Buchanich J, Ndoh C, Yuan J Prev Oncol Epidemiol. 2024; 2(1).

PMID: 39372673 PMC: 11451813. DOI: 10.1080/28322134.2024.2398014.

References
1.
Duffy S, Louzon S, Gritz E . Why do cancer patients smoke and what can providers do about it?. Community Oncol. 2012; 9(11):344-352. PMC: 3500959. DOI: 10.1016/j.cmonc.2012.10.003. View

2.
Mendez D, Le T . Consequences of a match made in hell: the harm caused by menthol smoking to the African American population over 1980-2018. Tob Control. 2021; . PMC: 8924008. DOI: 10.1136/tobaccocontrol-2021-056748. View

3.
Uribe M, Marrocco I, Yarden Y . EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. Cancers (Basel). 2021; 13(11). PMC: 8197917. DOI: 10.3390/cancers13112748. View

4.
Barta J, Powell C, Wisnivesky J . Global Epidemiology of Lung Cancer. Ann Glob Health. 2019; 85(1). PMC: 6724220. DOI: 10.5334/aogh.2419. View

5.
Liu Y, Wang Y, Jiang C . Inflammation: The Common Pathway of Stress-Related Diseases. Front Hum Neurosci. 2017; 11:316. PMC: 5476783. DOI: 10.3389/fnhum.2017.00316. View